IFIT5 and neoplasm: Two weeks after injection, the tumor volume of IFIT5-OE 5637 xenografts was significantly higher than the controls, in contrast, the tumor volume of IFIT5-KD UM-UC-3 xenografts was significantly smaller than the controls (Fig. 7a, b), indicating that IFIT5 could promote BCa development.